FLGT News and Press, Fulgent Genetics Inc. From 08/01/25

Linde plc (LIN) is expected to report $4.03 for Q2 2025 CNH Industrial N.V. (CNH) is expected to report $0.16 for Q2 2025 Piper Sandler Companies (PIPR) is expected to report $1.99 for Q2 2025 EchoStar Corporation (SATS) is expected to report $-1.12 for Q2 2025 LyondellBasell Indu...

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of $36.2 million, or Non-GAAP gross margin of 44.2% GAAP loss of $19.0 million, ...

Fulgent Genetics Inc. (FLGT) is expected to report $-0.56 for Q2 2025

2025-07-31 18:00:12 ET Major earnings expected before the bell on Friday include: Exxon Mobil Corporation ( XOM ) Chevron Corporation ( CVX ) Enbridge ( ENB ) Moderna ( MRNA ) The AES Corporation ( AES ) Read the full article on Seeking Alph...

2025-07-31 10:34:04 ET More on Fulgent Genetics Fulgent Genetics: A 'Sum Of The Parts' Story Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology Ful...

2025-07-27 08:00:26 ET Earnings season hits full stride next week, with an expansive slate of reports from tech titans, energy giants, financial firms, healthcare leaders and consumer names.... Read the full article on Seeking Alpha For further details see: Earning...

2025-07-17 10:16:20 ET More on Fulgent Genetics Fulgent Genetics: A 'Sum Of The Parts' Story Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology Ful...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced it has received CE certification under the European Union (EU)&#...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2025 financial results be...

2025-06-23 06:46:18 ET Today, I am putting Fulgent Genetics, Inc. ( FLGT ) in the spotlight for the first time here in 2025. I last looked at this diagnostic firm in late 2024. I concluded that article stating the company was making some progress, noting however the shar...